Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

More On COT.V

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Critical Outcome Technologies Inc. (COT.V)

-TSXV
0.28 Up 0.01(1.85%) Jul 23
ProfileGet Profile for:
Critical Outcome Technologies Inc.
700 Collip Circle
Suite 213
London, ON N6G 4X8
Canada - Map
Phone: 519-858-5157
Fax: 519-858-5179
Website: http://www.criticaloutcome.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Critical Outcome Technologies Inc. operates as a biotechnology company in Canada. The company focuses on applying CHEMSAS, a proprietary computer based technology, which identifies, profiles, optimizes, selects, and validates commercially viable drug candidates at the earliest stage of preclinical drug development. It develops drug candidates for the treatment of various cancers, such as small cell lung, acute myelogenous leukemia, ovarian, endometrial, pancreatic, brain, breast, and colon cancers, as well as human immunodeficiency virus, Alzheimer’s disease, and multiple sclerosis. The company’s lead oncology compound consists of COTI-2, a molecule in Phase I clinical trials, which acts by inhibiting protein kinase B phosphorylation that leads to caspase-9 activation in cancer cells resulting in tumor cell death. Critical Outcome Technologies Inc. is based in London, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Critical Outcome Technologies Inc.

Key Executives 
 PayExercised
Mr. John C. Drake Llb, 66
Exec. Chairman, Sr. Advisor and Member of The Bus. Advisory Board
2.00K0.00
Dr. Wayne R. Danter M.D., FRCPC,
Co-Founder, Chief Exec. Officer, Pres, Chief Scientific Officer, Director ,Chairman of Scientific Advisory Committee and Member of Audit Committee
172.00K0.00
Dr. Kathleen A. Ferguson M.D., FRCPC,
Co-Founder, Treasurer, Sec. and Member of Compensation Committee
2.00K0.00
Mr. Eugene Francis Kelly ,
Chief Financial Officer
131.00K0.00
Mr. Michael Barr ,
VP of Marketing and Bus. Devel.
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.